Lobbying client
QLIANCE
Scientific research on the development of a safe, effective and preventative AIDS vaccine.
Filings
15
Filed by
1
Reported in-house
—
Reported by firms
$87,180
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2009 to 2012
Filings
2 filings for 2012, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination 2nd Quarter 2012
|
KEVIN MCGUINESS PLLC | — reported |
|
1st Quarter - Report 1st Quarter 2012
|
KEVIN MCGUINESS PLLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| KEVIN MCGUINESS PLLC | 13 | $87,180 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 13 |
| Medicare/Medicaid | MMM | 6 |
| Medical/Disease Research/Clinical Labs | MED | 3 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.